Literature DB >> 10704430

Molecular genetics of holoprosencephaly.

L Nanni1, R L Schelper, M T Muenke.   

Abstract

Holoprosencephaly (HPE) is a common developmental defect of the human forebrain and midface. Pathological studies have identified different categories of severity of the brain and craniofacial malformations observed in HPE, although the variable clinical spectrum of HPE extends in unbroken sequence from alobar HPE and cyclopia to clinically unaffected carriers in familial HPE. The etiology of HPE is extremely heterogeneous including both environmental and genetic causes. Here we focus on molecular aspects of HPE in light of the recent identification of some of the genes causing human HPE and other candidate genes involved in forebrain development, through different approaches, such as positional cloning and functional cloning, based on animal models. These approaches will aid in the identification of additional genes involved in HPE and in a better understanding of the molecular genetics of brain development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704430     DOI: 10.2741/nanni

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  10 in total

1.  Multicolour FISH and quantitative PCR can detect submicroscopic deletions in holoprosencephaly patients with a normal karyotype.

Authors:  C Bendavid; B R Haddad; A Griffin; M Huizing; C Dubourg; I Gicquel; L R Cavalli; L Pasquier; A L Shanske; R Long; M Ouspenskaia; S Odent; F Lacbawan; V David; M Muenke
Journal:  J Med Genet       Date:  2005-09-30       Impact factor: 6.318

2.  Genetically induced abnormal cranial development in human trisomy 18 with holoprosencephaly: comparisons with the normal tempo of osteogenic-neural development.

Authors:  Shaina N Reid; Janine M Ziermann; Marjorie C Gondré-Lewis
Journal:  J Anat       Date:  2015-05-28       Impact factor: 2.610

3.  Cyclopia: isolated and with agnathia-otocephaly complex.

Authors:  Lin Tun Wai; Suresh Chandran
Journal:  BMJ Case Rep       Date:  2017-08-30

4.  Semilobar Holoprosencephaly with Neurogenic Hypernatraemia: Two new cases.

Authors:  Hashim Javad; Saif Al-Yarubi; Alexander P Chacko; Dilip Sankhla; Amna Al-Futasi; Anas A Abdelmogheth; Mohamed El-Naggari
Journal:  Sultan Qaboos Univ Med J       Date:  2013-06-25

Review 5.  Facial Morphogenesis: Physical and Molecular Interactions Between the Brain and the Face.

Authors:  Ralph Marcucio; Benedikt Hallgrimsson; Nathan M Young
Journal:  Curr Top Dev Biol       Date:  2015-10-19       Impact factor: 4.897

Review 6.  Alobar holoprosencephaly associated with a rare chromosomal abnormality: Case report and literature review.

Authors:  Crîngu Antoniu Ionescu; Dan Calin; Dan Navolan; Alexandra Matei; Mihai Dimitriu; Catalin Herghelegiu; Liana Ples
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

7.  SHH signaling mediated by a prechordal and brain enhancer controls forebrain organization.

Authors:  Tomoko Sagai; Takanori Amano; Akiteru Maeno; Rieko Ajima; Toshihiko Shiroishi
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-04       Impact factor: 11.205

8.  Smith-Lemli-Opitz syndrome - Fetal phenotypes with special reference to the syndrome-specific internal malformation pattern.

Authors:  Katharina Schoner; Martina Witsch-Baumgartner; Jana Behunova; Robert Petrovic; Rainer Bald; Susanne G Kircher; Annette Ramaswamy; Britta Kluge; Matthias Meyer-Wittkopf; Ralf Schmitz; Barbara Fritz; Johannes Zschocke; Franco Laccone; Helga Rehder
Journal:  Birth Defects Res       Date:  2019-12-16       Impact factor: 2.344

9.  Histogenesis of retinal dysplasia in trisomy 13.

Authors:  Ada Chan; Satyan Lakshminrusimha; Reid Heffner; Federico Gonzalez-Fernandez
Journal:  Diagn Pathol       Date:  2007-12-18       Impact factor: 2.644

10.  Asymptomatic Hypernatremia in an Infant with Midline Defects.

Authors:  Sangeetha Geminiganesan; Padmasani Venkat Ramanan; Dhivyalakshmi J; Bhogavalli Lakshmi Harshita; Deepalakshmi Sriram
Journal:  EJIFCC       Date:  2021-12-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.